PharmEasy’s parent firm API Holdings cut down its advertising and promotional expenses to Rs 235 crore, less than half of what it incurred ...

Tata 1mg had a 31% market share in September 2023 against 19% in October 2022 while PharmEasy slipped to 15% from about 33% during the same...

Pai is also joining the board of PharmEasy and is expected to work with CEO Shah. He will retain the board seats as long as his holding doe...

Mumbai-based epharmacy platform PharmEasy is likely to be valued at $500-600 million compared to the $5.6 billion valuation in 2021

PharmEasy was supposed to raise equity of around Rs 1,000 crore, or about $120 million, linked to its burn rate velocity. It has failed to ...

We are already in June, the year is racing past. Hope you have an interesting summer planned ahead. In April, Apple opened two company-owne...

Online pharmacy PharmEasy recorded a positive ebitda of around Rs 14 crore, which means it is operationally profitable, even as one of its ...

The epharmacy held discussions with CDPQ, ADQ; convertible notes are also being discussed amid valuation corrections and markdowns.

The calendar year 2022 saw online platforms like Flipkart, Amazon overtake offline retailers in shipments of smartphones from manufacturing...

PharmEasy’s parent API Holdings has also delayed internal plans for a potential initial public offering (IPO) to 2025, the people privy to ...

Existing investors will also put in $70 million, valuation at $2.5-$2.75 versus $5.4 billion of last year’s pre-IPO round. IPO is shelved f...

The Mumbai-based firm is also stitching up a private financing round through a rights issue where company founders are expected to invest p...

FirstCry turned profitable in fiscal year 2021, as per recent regulatory filings, clocking a net profit of nearly Rs 216 crore compared wit...

Thyrocare Technologies Ltd., incorporated in the year 2000, is a Mid Cap company (having a market cap of Rs 5758.02 Crore) operating in Hos...

Thyrocare is primarily a B2B diagnostic services provider. With PharmEasy’s presence, it will no longer be seen as a conventional diagnosti...

Bengaluru startup’s acquisition indicates early signs of consolidation in the sector

The funding indicates continued interest in the online pharmacy segment despite a reported dip in the total investment secured by startups ...